StayHappi Darifenacin 15mg Tablet is a muscarinic antagonist that is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination.

StayHappi Darifenacin 15mg Tablet is used to treat symptoms of overactive bladder that include sudden urge to pass urine, uncontrollable desire to pass urine, etc.

Uses of StayHappi Tablet

Treatment of Overactive bladder (OAB) symptoms

Benefits of StayHappi Tablet

In Treatment of Overactive bladder (OAB) symptoms

StayHappi Darifenacin 15mg Tablet helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.

Side effects of StayHappi Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of StayHappi

Constipation
Dryness in mouth
Headache
Dry eye
Nasal dryness

How to use StayHappi Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. StayHappi Darifenacin 15mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with StayHappi Darifenacin 15mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

StayHappi Darifenacin 15mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

StayHappi Darifenacin 15mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

StayHappi Darifenacin 15mg Tablet may cause side effects which could affect your ability to drive.
StayHappi Darifenacin 15mg Tablet may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. This may affect your driving ability.

Kidney

SAFE IF PRESCRIBED

StayHappi Darifenacin 15mg Tablet is safe to use in patients with kidney disease. No dose adjustment of StayHappi Darifenacin 15mg Tablet is recommended.
However, inform your doctor if you have any underlying kidney disease.

Liver

CAUTION

StayHappi Darifenacin 15mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of StayHappi Darifenacin 15mg Tablet may be needed. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

StayHappi Darifenacin 15mg Tablet

₹23.5/Tablet

Urifen 15mg Tablet

Ajanta Pharma Ltd

₹39.5/tablet

68% costlier

Xelena 15mg Tablet

Dr Reddy's Laboratories Ltd

₹39.5/tablet

68% costlier

DERITAS 15 MG TABLET

Intas Pharmaceuticals Ltd

₹39.5/tablet

68% costlier

Quick tips

StayHappi Darifenacin 15mg Tablet helps you to have better control over your urination by relaxing your bladder which increases its capacity to hold urine, thereby reducing the need to pass urine.
It may cause blurred vision, fatigue and sleepiness. Be cautious while driving or doing anything that requires focus.
It may cause dry mouth. Try chewing on sugar-free gum or taking small sips of water.
Avoid caffeine, alcohol or carbonated drinks as they can worsen your symptoms.
Do not stop taking this medicine if you do not notice an improvement in your symptoms as it may take some time for your bladder to adapt and your symptoms to improve.

Fact Box

Chemical Class

Diphenylmethane Derivative

Habit Forming

Therapeutic Class

UROLOGY

Action Class

Selective M3 anticholinergic (Bladder)

Patient concerns

I feel some time to urine again after urine but no pain fever burning sensation last time I show to one doctor can u check the report is any abnormal This microsopic report is normal

Dr. Praveen Pushkar

Urology

U may be having overactive bladder get urodynamics bladder pressure study

Sir my daughter PATIENT a uti patient.puss cells are 10-15 .urine culture is normal. Usg shows overactive bladder she is taking dariff And contiflo.how much time will it take for her treatment with this medicine.

Dr. Praveen Pushkar

Urology

y is she taking contiflo icon for overactive bladder

Uncontrollably urine and bed wetting I had spina bifida when I born, so I have a problem in controlling urine and the main problem is bed wetting while sleeping

Dr. Praveen Pushkar

Urology

There is nothing much u can do get urine routine examination n culture ultrasound kub with PVR u r having overactive bladder probably u can start anti cholinergics after consulting ur local if ur reports are normal

Related lab tests

Urine Routine & Microscopy

Top Urogynecologists

4.4 ★

0 ★

MBBS, MS, Diploma, DNB, Fellowship, Fellowship

4.8 ★

4 ★

0 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 359.
Darifenacin. Luxembou: Merus Labs Luxco II S.à R.L; 2004 [revised 12 Jan. 2015]. [Accessed 04 Apr. 2019] (online) Available from:
Drugs.com.Darifenacin. [Accessed 04 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:

Marketer details

Name: Sarvagunaushdhi Pvt Ltd

Address: 13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.